MwanzoDBVT • NASDAQ
add
DBV Technologies SA - ADR
$ 7.79
Baada ya Saa za Kazi:(5.26%)-0.41
$ 7.38
Imefungwa: 14 Apr, 16:19:39 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 7.32
Bei za siku
$ 7.33 - $ 7.80
Bei za mwaka
$ 2.20 - $ 8.50
Thamani ya kampuni katika soko
196.80M USD
Wastani wa hisa zilizouzwa
elfu 805.64
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 560.00 | -93.69% |
Matumizi ya uendeshaji wa biashara | 24.33M | 17.00% |
Mapato halisi | -23.00M | -105.59% |
Kiwango cha faida halisi | elfu -4.11 | -3,158.18% |
Mapato kwa kila hisa | -0.21 | 89.44% |
EBITDA | — | — |
Asilimia ya kodi ya mapato | -0.23% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 46.44M | -67.15% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 54.03M | — |
hisa zilizosalia | 100.84M | — |
Uwiano wa bei na thamani | 13.07 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | -96.72% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -23.00M | -105.59% |
Pesa kutokana na shughuli | -12.28M | 10.29% |
Pesa kutokana na uwekezaji | elfu 750.00 | 501.07% |
Pesa kutokana na ufadhili | elfu 688.00 | 464.02% |
Mabadiliko halisi ya pesa taslimu | -13.97M | -79.89% |
Mtiririko huru wa pesa | — | — |
Kuhusu
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
Ilianzishwa
29 Mac 2002
Tovuti
Wafanyakazi
108
